233 related articles for article (PubMed ID: 10097113)
101. JNK targets p53 ubiquitination and degradation in nonstressed cells.
Fuchs SY; Adler V; Buschmann T; Yin Z; Wu X; Jones SN; Ronai Z
Genes Dev; 1998 Sep; 12(17):2658-63. PubMed ID: 9732264
[TBL] [Abstract][Full Text] [Related]
102. MAPK-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival.
Yu YL; Chiang YJ; Chen YC; Papetti M; Juo CG; Skoultchi AI; Yen JJ
J Biol Chem; 2005 Aug; 280(33):29533-42. PubMed ID: 15967790
[TBL] [Abstract][Full Text] [Related]
103. Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemia in vivo.
Bates DJ; Lewis LD; Eastman A; Danilov AV
Br J Clin Pharmacol; 2015 Sep; 80(3):493-501. PubMed ID: 25753324
[TBL] [Abstract][Full Text] [Related]
104. Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication.
Nencioni L; De Chiara G; Sgarbanti R; Amatore D; Aquilano K; Marcocci ME; Serafino A; Torcia M; Cozzolino F; Ciriolo MR; Garaci E; Palamara AT
J Biol Chem; 2009 Jun; 284(23):16004-15. PubMed ID: 19336399
[TBL] [Abstract][Full Text] [Related]
105. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.
Yamamoto K; Ichijo H; Korsmeyer SJ
Mol Cell Biol; 1999 Dec; 19(12):8469-78. PubMed ID: 10567572
[TBL] [Abstract][Full Text] [Related]
106. Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study.
Wiraswati HL; Bashari MH; Alfarafisa NM; Ma'ruf IF; Sholikhah EN; Wahyuningsih TD; Satriyo PB; Mustofa M; Satria D; Damayanti E
Adv Appl Bioinform Chem; 2024; 17():33-46. PubMed ID: 38435441
[TBL] [Abstract][Full Text] [Related]
107. Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment.
Al Amin M; Emran TB; Khan J; Zehravi M; Sharma I; Patil A; Gupta JK; Jeslin D; Krishnan K; Das R; Nainu F; Ahmad I; Wilairatana P
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001572
[TBL] [Abstract][Full Text] [Related]
108. JNK Cascade-Induced Apoptosis-A Unique Role in GqPCR Signaling.
Nadel G; Maik-Rachline G; Seger R
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686335
[TBL] [Abstract][Full Text] [Related]
109. Inhibition of TNF-
Ren S; Huang T; Ou D; Feng L; Huang S; Zhou C; Ge L
Appl Bionics Biomech; 2022; 2022():8460121. PubMed ID: 36016921
[TBL] [Abstract][Full Text] [Related]
110. Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via mTORC1/S6K Signaling Pathway.
Kim G; Jang SK; Kim YJ; Jin HO; Bae S; Hong J; Park IC; Lee JH
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955892
[TBL] [Abstract][Full Text] [Related]
111. HAX1 maintains the glioma progression in hypoxia through promoting mitochondrial fission.
Lin J; Wang Y; Lin Z
J Cell Mol Med; 2021 Dec; 25(24):11170-11184. PubMed ID: 34755451
[TBL] [Abstract][Full Text] [Related]
112. δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis.
Fontana F; Marzagalli M; Raimondi M; Zuco V; Zaffaroni N; Limonta P
Cell Prolif; 2021 Nov; 54(11):e13111. PubMed ID: 34520051
[TBL] [Abstract][Full Text] [Related]
113. SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models.
Zhao X; Kong W; Tucker K; Staley A; Fan Y; Sun W; Yin Y; Huang Y; Fang Z; Wang J; Sen S; Dugar S; Zhou C; Bae-Jump VL
Am J Transl Res; 2020; 12(8):4264-4276. PubMed ID: 32913503
[TBL] [Abstract][Full Text] [Related]
114. Conformational States of the Cytoprotective Protein Bcl-xL.
Ryzhov P; Tian Y; Yao Y; Bobkov AA; Im W; Marassi FM
Biophys J; 2020 Oct; 119(7):1324-1334. PubMed ID: 32888404
[TBL] [Abstract][Full Text] [Related]
115. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
[TBL] [Abstract][Full Text] [Related]
116. Understanding MAPK Signaling Pathways in Apoptosis.
Yue J; López JM
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231094
[TBL] [Abstract][Full Text] [Related]
117. The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner.
Hüsemann LC; Reese A; Radine C; Piekorz RP; Budach W; Sohn D; Jänicke RU
Cell Cycle; 2020 Feb; 19(4):464-478. PubMed ID: 31959066
[TBL] [Abstract][Full Text] [Related]
118. Systems analysis of phosphorylation-regulated Bcl-2 interactions establishes a model to reconcile the controversy over the significance of Bcl-2 phosphorylation.
Song T; Wang P; Yu X; Wang A; Chai G; Fan Y; Zhang Z
Br J Pharmacol; 2019 Feb; 176(3):491-504. PubMed ID: 30500985
[TBL] [Abstract][Full Text] [Related]
119. Regulation of apoptosis by an intrinsically disordered region of Bcl-xL.
Follis AV; Llambi F; Kalkavan H; Yao Y; Phillips AH; Park CG; Marassi FM; Green DR; Kriwacki RW
Nat Chem Biol; 2018 May; 14(5):458-465. PubMed ID: 29507390
[TBL] [Abstract][Full Text] [Related]
120. Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.
Saatci Ö; Borgoni S; Akbulut Ö; Durmuş S; Raza U; Eyüpoğlu E; Alkan C; Akyol A; Kütük Ö; Wiemann S; Şahin Ö
Oncogene; 2018 Apr; 37(17):2251-2269. PubMed ID: 29391599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
